Clinical Trial on a Topical "Antiage" Face Gel

• Status: Completed
• Trial end date: 2013-02-01
• Target enrollment: 0
• Participant gender: Female

Summary

Aim of the study is to evaluate clinically and by non-invasive instrumental evaluations the "antiage" activity of Gynomunal® gel after one single application on the face (short term evaluation) and 4 weeks of repeated use twice daily (long term evaluation) by healthy female volunteers.

It is also aim of this study to evaluate cosmetic acceptability by the volunteers and efficacy and tolerance both by investigator and volunteers.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Derming SRL

Criteria

Inclusion Criteria:

• female healthy subjects;

• age 35-65 years;

• presence of light-moderate face ritidosis;

• agreeing to present at each study visit without make-up;

• accepting to not change their habits regarding food, physical activity, face cleansing and make- up use;

• accepting not to expose their face to strong UV irradiation (UV session, or sun bathes) during the entire duration of the study;

• accepting to sign the Informed consent form

Exclusion Criteria:

• Pregnancy;

• lactation;

• change in the normal habits regarding foods, physical activity, face cleansing and make-up use during the month preceding the test;

• sensitivity to the test product or its ingredients;

• subjects whose insufficient adhesion to the study protocol is foreseeable;

• participation in a similar study actually or during the previous 3 months;

• change in the normal life habits during the month preceding the inclusion.

• dermatitis;

• presence of cutaneous disease on the tested area, as lesions, scars, malformations;

• recurrent facial/labial herpes;

• clinical and significant skin condition on the test area (e.g. active eczema, dermatitis, psoriasis etc.).

• diabetes

• endocrine disease

• hepatic disorder

• renal disorder

• cardiac disorder

• pulmonary disease

• cancer

• neurological or psychological disease

• inflammatory/immunosuppressive disease

• drug allergy.